Federal Register / Vol. 86, No. 26 / Wednesday, February 10, 2021 / Notices 8915 

certain information to assure the dutyfree entry of the supplies. 

e. Construction provisions and 

clauses: 

• 52.225–9, Buy American— 

Construction Materials 

• 52.225–10, Notice of Buy American 

Requirement—Construction Materials 

• 52.225–11, Buy AmericanConstruction Materials Under Trade 

Agreements 

• 52.225–12, Notice of Buy American 

Requirement—Construction Materials 

under Trade Agreements 

• 52.225–21, Required Use of American 

Iron, Steel and Manufactured Goods— 

Buy American—Construction 

Materials 

• 52.225–23, Required Use of American 

Iron, Steel and Manufactured Goods— 

Buy American—Construction 

Materials Under Trade Agreements 

The listed provisions and clauses 

provide that an offeror or contractor 

requesting to use foreign construction 

material due to unreasonable cost of 

domestic construction material shall 

provide adequate information to permit 

evaluation of the request. 

C. Annual Burden 

Respondents: 8,771. 

Total Annual Responses: 43,891. 

Total Burden Hours: 40,738. 

D. Public Comment 

A 60-day notice was published in the 

Federal Register at 85 FR 63276, on 

October 7, 2020. No comments were 

received. 

Obtaining Copies: Requesters may 

obtain a copy of the information 

collection documents from the GSA 

Regulatory Secretariat Division, by 

calling 202–501–4755 or emailing 

GSARegSec@gsa.gov. Please cite OMB 

Control No. 9000–0024, Buy American, 

Trade Agreements, and Duty-Free Entry. 

Janet Fry, 

Director, Federal Acquisition Policy Division, 

Office of Governmentwide Acquisition Policy, 

Office of Acquisition Policy, Office of 

Governmentwide Policy. 

[FR Doc. 2021–02689 Filed 2–9–21; 8:45 am] 

BILLING CODE 6820–EP–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

Panel 1, Panel 2, and Panel 3: GH21– 

003, Advancing Public Health Research 

in Kenya; GH21–004, Conducting 

Research to Inform Pandemic Response 

and Recovery of Emergency-Affected 

Populations by Determining Public 

Health Needs, Improving Methods, and 

Integrating Services to Mitigate 

Morbidity and Mortality; and GH21– 

006, Strengthening Public Health 

Research and Implementation Science 

(Operations Research) to Control and 

Eliminate Infectious Diseases Globally. 

Dates: March 30–31, 2021 and April 

1, 2021. 

Time: 9:00 a.m.–2:00 p.m., EDT. 

Place: Teleconference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Hylan Shoob, Ph.D., Scientific Review 

Officer, Center for Global Health, CDC, 

1600 Clifton Drive, Atlanta, Georgia 

30329–4027, Telephone (404) 639–4796, 

HShoob@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–02738 Filed 2–9–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP)–DP21–002, 

Epidemiologic Cohort Study of 

Interstitial Cystitis; Amended Notice of 

Meeting 

Notice is hereby given of a change in 

the meeting of the Disease, Disability, 

and Injury Prevention and Control 

Special Emphasis Panel (SEP)–DP21– 

002, Epidemiologic Cohort Study of 

Interstitial Cystitis, March 30, 2021, 

10:00 a.m.–6:00 p.m., EST, which was 

published in the Federal Register on 

Friday, December 11, 2020, Volume 85, 

Number 239, page 80107. 

The meeting on March 30, 2021 is 

being amended to change the time and 

should read as follows: 

Time: 12:00 p.m.–3:00 p.m., EDT. 

The meeting is closed to the public. 

For Further Information Contact: Jaya 

Raman, Ph.D., Scientific Review Officer, 

National Center for Chronic Disease 

Prevention and Health Promotion, CDC, 

4770 Buford Highway, Mailstop S107–8, 

Atlanta, Georgia 30341, Telephone (770) 

488–6511, JRaman@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–02736 Filed 2–9–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,